In addition, we found that BSTZC and its active components could ameliorate lipid abnormalities and liver injury, and BSTZC could alleviate HLP by modulating the PI3K/Akt pathway. This evidence concerns the gene PIK3CA and hyperkeratosis lenticularis perstans.